Caribou Biosciences Announces FDA Clearance for Genome-edited CAR-T Cell Therapy

https://cariboubio.com/in-the-news/press-releases/caribou-biosciences-announces-fda-clearance-its-ind-cb-010-the-shelf
JOIN OUR MAILING LIST

 

 
 
 
 

IPIRA is committed to meeting the needs of people with disabilities in a timely manner by preventing and removing barriers to accessibility. We also adhere to the UC Berkeley policy on nondiscrimination, and protect the privacy of confidential information.